| Pfizer AG - Vizimpro 45 mg, Filmtabletten | | 66774 | | 03 | | Vizimpro 45 mg | | Filmtabletten | | L01EB07 | | Dacomitinib | | 27.08.2019 | | |
| | Composition | | dacomitinibum 45 mg ut dacomitinibum monohydricum 46.729 mg, cellulosum microcristallinum, lactosum monohydricum 121.386 mg, carboxymethylamylum natricum A corresp. natrium max. 0.378 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, E 171, macrogolum 3350, E 132, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Dacomitinibum | 45 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | Lactose Monohydrate | 121.386 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
